help + privacy policy + contact us + links + home
 
About APhACareerse-CommunitiesMeetingsPublicationsJoin APhA
Scientists  

APhA2010 Annual Meeting Washington DC

APhA CEO Blog

APhA 
Foundation


Print this page

APhA Academy of Pharmaceutical Research and Science (APhA-APRS)

The Scientific Voice of Pharmacy

In addition to resources for practitioners, APhA also stimulates the discovery, dissemination and application of research to improve patient health and serves pharmacists and those members who are involved in the pharmaceutical sciences.

Members of APhA may choose to belong to a primary section within APhA-Academy of Pharmaceutical Research and Science (APhA-APRS) based on their area of research. Members may belong to as many sections within APhA-APRS as they wish. APhA-APRS is governed by an Executive Council comprised of elected leaders from the three Sections of APhA-APRS: Basic Sciences, Clinical Sciences and Economic, Social and Administrative Sciences.

Members receive access to continuing education, an online community for pharmacists, networking and leadership opportunities, premier research journals such as JAPhA and JPharmSci, cutting edge information on Medication Therapy Management, and regulatory issues facing the profession.

Are you a Postgraduate in the Pharmaceutical Sciences?  Get involved in Academy activities by learning more about the Postgraduate Initiative.  

Meet the 2008-2010 APhA-APRS President:

 Image

L. Douglas Ried, PhD

Dr. Ried is Dean and Professor at the College of Pharmacy, Southwestern Oklahoma State University. Dr. Ried is an APhA Fellow and served as ESAS Section Chair; Vice Chair, Quality Assessment and Improvement STAT; Policy Committee Chair and Member; and, APhA-ASP Advisor and House Delegate for over 20 years. With over 60 peer-reviewed publications, he conducts research into medications’ effects on patients' quality of life and psychosocial aspects of psychotropic drug use, with current investigations into the link between antihypertensive medications and depressive symptoms, the role of antidepressants in post-stroke recovery, and the association between second-generation antipsychotics and metabolic dysfunction. He is a JAPhA Associate Editor. 

 

Meet the APhA-APRS President-elect: 

  Image 

Walter G. Chambliss, PhD,

Dr. Chambliss is Director of Technology Management and Professor of Pharmaceutics at the University of Mississippi.  He received his BS degree in Pharmacy in 1977, MS degree in Pharmaceutics in 1980, and a PhD in Pharmaceutics in 1982 from the University of Mississippi. He worked for 17 years in R&D in the pharmaceutical industry at G.D. Searle, Bristol-Myers, and Schering-Plough, where he was Vice-President of R&D.  He has been active in APhA–APRS as an officer in the Basic Sciences Section and as a member of the International Steering Committee for APhA’s Handbook of Pharmaceutical Excipients.